Parnassus Investments, LLC Dexcom Inc Transaction History

Parnassus Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$86.06 - $137.93 $7,917 - $12,689	92 Added 3.63%	2,626 $245,000
Q1 2023 May 01, 2023	BUY	$104.0 - $122.92 $67,080 - $79,283	645 Added 34.15%	2,534 $294,000
Q4 2022 Jan 30, 2023	BUY	$84.98 - $122.67 $160,527 - $231,723	1,889 New	1,889 $213,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Parnassus Investments, LLC with notifications on news.